Finerenone is the first non-steroidal selective mineralocorticoid receptor antagonist, which can be used for the treatment of diabetic nephropathy, chronic kidney disease and end-stage renal disease.
Inventory Status
Ready Stock
Please as a distributor to view package sizes and prices